November 1, 2024 · STOCK Act disclosure
Representative Jonathan L. Jackson (Democrat-IL) sold Regeneron Pharmaceuticals, Inc., a stock transaction, valued at $1,001 - $15,000. The trade took place on November 1, 2024 and was disclosed on December 12, 2024 (owner: Joint). Members of Congress must report such transactions within 45 days under the STOCK Act.